Prevention of multiple organ dysfunction syndrome by modulation of the expression of endotoxin receptors (TLR4,RP105) on PBMC
Prevention of multiple organ dysfunction syndrome by modulation of the expression of endotoxin receptors (TLR4,RP105) on PBMC
批准号:
15591925
负责人:
HIROHASHI Nobuyuki
金额:
$1.09万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004
中文摘要
点击翻译按钮获取中文摘要
英文摘要
TLR4, may recognize and signal LPS, is a leucine-rich repeat(LRR) molecule. RP105 is known as another LRR molecule that may sense pathogen invasion and activate B cells. In the present study, we analyzed the surface expression of TLR4 and RP105 on PBMC in SIRS/SEPSIS patients. The expression of TLR4,RP105 and various markers on PBMC in SIRS/SPSIS patients was analyzed using monoclonal antibodies and flowcytometry. In monocytes, all CD11b or CD14-positive cells were TLR4 or RP105 positive. In lymphocytes, all CD3-positive cells from the subject of the normal or the SIRS/SEPSIS patients, were TLR4 and RP105 negative. All CD19-positive cells from the normal subject were RP105 positive, those from the SIRS/SEPSIS patient contained a large number of RP105-negative B cells. There were no correlation between the cell numbers of RP105-negative B cells and serum endotoxin concentration, however there were correlation between the cell numbers of RP105-negative B cells and the score numbers of SIRS and SOFA. These findings suggested that RP105-negative B cells may play an important role in SIRS/SEPSIS. On the other hand, The expressions of TLR4 and RP105 on monocytes were down-regulated in SIRS/SEPSIS. There were correlation between the concentration of an acute phase molecule MIF(macrophage migration inhibitory factor) and those of other acute phase molecules IL-6/IL-10 in plasma. Interestingly, there were also correlation between the concentration of HMBG1(high mobility group box 1), the late phase molecule in SIRS/SEPSIS, and that of MIF. However there were no correlation between the expressions of TLR4/RP105 on monocytes and the concentrations of MIF/HMG1 in plasma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
基于TLR4/NF-κB通路与耐药基因调控探讨温阳化气汤治疗耐碳青霉烯鲍曼不动杆菌肺炎的作用机制
-
批准号:JCZRLH202600367
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向中性粒细胞胞外诱捕网-TLR4通路逆转Treg细胞介导的代谢相关脂肪肝肝癌免疫治疗抵抗的机制研究
-
批准号:2026JJ60391
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李桃
-
依托单位:
丁酸梭菌分泌的丁酸通过TLR4/NF-κB信号通路调控ICCs介导ICH后胃肠动力的机制研究
-
批准号:2026JJ80329
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘艳辉
-
依托单位:
片仔癀通过调控TLR4/NF-κB/Nrf2通路减轻大面积烧伤后肠道屏障损伤的机制研究
-
批准号:2026JJ80347
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李波
-
依托单位:
干葛散调控TLR4/MyD88/NF-κB轴改善HaCat细胞炎症反应治疗特应性皮炎作用机制研究
-
批准号:2026JJ81892
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张小娟
-
依托单位:
基于TLR4/P38MAPK/NF-ΚB通路的栀子苷和大黄素配伍抗脓毒症肠屏障炎性损伤研究
-
批准号:2026JJ81968
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:邓怒骄
-
依托单位:
基于"瘀毒互结"理论探讨补阳还五汤调节TLR4/NF-κB通路促进缺血性脑卒中神经再生的机制研究
-
批准号:JCZRLH202600185
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
经穴推拿通过miR-216a-5p调控TLR4/NF-κB/NLRP3信号通路抑制椎间盘退变炎症和焦亡的机制研究
-
批准号:JCZRLH202601300
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于肠-眼轴探究枸杞外泌体通过调控TLR4/NLRP3/GSDMD在糖尿病性视网膜病变中的作用及机制研究
-
批准号:2026JJ81535
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:欧宜文
-
依托单位:
rTMS通过调节Syt6/TLR4信号通路上调外周调节性T细胞比例改善帕金森病相关免疫失衡的机制研究
-
批准号:2026JJ81581
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘银花
-
依托单位: